Eli Lilly & Co. (LLY), Adocia Announce Positive Top-Line Data from BioChaperone Lispro Phase 1
Tweet Send to a Friend
Adocia and Eli Lilly and Company (NYSE: LLY) announced positive topline results from a Phase 1 clinical trial evaluating BioChaperone ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE